Objective: To investigate the application status and influencing factors of statins in different populations in Baotou area, so as to provide data reference for making accurate prevention and control strategies to cardiovascular diseases (CVD). Methods: From June 2021 to September 2022, residents over 40 years old in Baotou area were randomly selected by multi-stage cluster and random sampling. The general information, cognition level of cardiovascular and cerebrovascular disease, and application of statins of the research objects were collected and registered by questionnaire. The participants were divided into the CVD group, CVD risk-factor group, and normal group. Logistic regression analysis was used to evaluate the CVD influencing factors in each group. Results: A total of 2 100 valid respondents were registered. The averase age was (58.7±11.0) years,ranging from 40 to 94, male accounted for 45.1% (n=948). Among them, 14.2% (298) had a history of cardiovascular and cerebrovascular disease (CVD), 49.5% (1 040) had no CVD but risk factors, and 36.3% (762) had no CVD and risk factors. The proportion of statins use was 14.8% in Baotou area, with 46.3%, 14.2% and 3.1% in the three groups respectively. Multivariate analysis showed that women in the CVD group were less likely to take statins. Advanced age, hypertension, diabetes and high CVD awareness were positively associated with application of statins. Multivariate analysis of the CVD risk-factor group suggest that people with older age and higher cognition level of CVD were more likely to use statin, while rural, smoking and obesity population were less likely to take stains. The proportion of reasons for taking statins in the normal group were self-awareness of taking statins>introduction of relatives and friends>advertising and media publicity>doctor’s prescription. Conclusion: In Baotou area, the application of statins in the secondary prevention and primary prevention of cardiovascular and cerebrovascular diseases is not standard. There were great differences among different subgroups of population, and there are overmedication in the normal population.
BAI Ruyu
,
WU Li’e
,
GUO Xia
,
ZHANG Jia
,
YU Wenlong
,
YU Yanxue
. Application status and influencing factors of statins in Baotou area[J]. Journal of Baotou Medical College, 2024
, 40(1)
: 79
-84
.
DOI: 10.16833/j.cnki.jbmc.2024.01.014
[1] 诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953.
[2] Ngo-Metzger Q, Zuvekas S, Shafer P, et al. Statin use in the U.S. for secondary prevention of cardiovascular disease remains suboptimal[J]. Journal of the American Board of Family Medicine: JABFM, 2019, 32(6): 807-817.
[3] 中国心血管病风险评估和管理指南[J]. 中国循环杂志, 2019, 34(1): 4-28.
[4] 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4): 20-36, 40.
[5] Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries[J]. N Engl J Med, 2014, 371(9): 818-827.
[6] Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle and coronary disease[J]. N Engl J Med, 2016, 375(24): 2349-2358.
[7] 严卿维, 龚戬芳, 吴晓鸣, 等. 300名社区居民健商与心血管疾病认知水平的相关性研究[J]. 护理学报, 2017, 24(23): 37-40.
[8] Pastor-Barriuso R, Padrón-Monedero A, Parra-Ramírez LM, et al. Social engagement within the facility increased Life expectancy in nursing home residents: a follow-up study[J]. BMC Geriatrics, 2020, 20(1): 480.
[9] Lee TH, Hsu WC, Chen CJ, et al. Etiologic study of young ischemic stroke in Taiwan[J]. Stroke, 2002, 33: 1950-1955.
[10] Lewey J, Shrank WH, Bowry ADK, et al. Gender and racial disparities in adherence to statin therapy: A meta-analysis[J]. Am Heart J, 2013, 165(5): 665-78, 678.
[11] Lu J, Zhang L, Lu Y, et al. Secondary prevention of cardiovascular disease in China[J]. Heart, 2020, 106(17): 1349-1356.
[12] Zhang JY, Lu N. What matters most for community social capital among older adults living in urban China: the role of health and family social capital[J]. Int J Environ Res Public Health,2019, 16(4): 558.
[13] Lu JP, Lu Y, Yang H, et al. Characteristics of high cardiovascular risk in 1.7 million Chinese adults[J]. Ann Intern Med, 2019, 170(5): 298-308.
[14] 中国心血管病一级预防指南[J]. 实用心脑肺血管病杂志, 2021, 29(1): 44, 64.
[15] Jun JE, Jeong IK, Ahn KJ, et al. Statin use for primary prevention in patients with type 2 diabetes: can it benefit all ages-A nationwide propensity-matched cohort study[J]. Diabetes Res Clin Pract, 2021, 180: 109044.